U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C21H31N3O3
Molecular Weight 373.4891
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of D-3263

SMILES

COC1=CC=C2N(C(=O)[C@@H]3C[C@H](C)CC[C@H]3C(C)C)C(=O)N(CCN)C2=C1

InChI

InChIKey=ZGTYTFYRCIRWBL-HYVNUMGLSA-N
InChI=1S/C21H31N3O3/c1-13(2)16-7-5-14(3)11-17(16)20(25)24-18-8-6-15(27-4)12-19(18)23(10-9-22)21(24)26/h6,8,12-14,16-17H,5,7,9-11,22H2,1-4H3/t14-,16+,17-/m1/s1

HIDE SMILES / InChI

Approval Year

Name Type Language
D-3263
Code English
D 3263 [WHO-DD]
Common Name English
3-(2-AMINOETHYL)-1-((1R,2S,5R)-2-ISOPROPYL-5-METHYL-CYCLOHEXANECARBONYL)-5-METHOXY-BENZIMIDAZOL-2-ONE
Systematic Name English
2H-BENZIMIDAZOL-2-ONE, 3-(2-AMINOETHYL)-1,3-DIHYDRO-5-METHOXY-1-(((1R,2S,5R)-5-METHYL-2-(1-METHYLETHYL)CYCLOHEXYL)CARBONYL)-
Systematic Name English
D-3263 (FREE BASE)
Code English
Code System Code Type Description
PUBCHEM
44137358
Created by admin on Sat Dec 16 18:20:54 GMT 2023 , Edited by admin on Sat Dec 16 18:20:54 GMT 2023
PRIMARY
CLINICAL_TRIALS.GOV
D-3263 (FREE BASE)
Created by admin on Sat Dec 16 18:20:54 GMT 2023 , Edited by admin on Sat Dec 16 18:20:54 GMT 2023
PRIMARY Official Title: A Phase 1, Open Label, Dose Escalation Study Evaluating the Safety and Pharmacokinetics of Enteric Coated D-3263 Hydrochloride in Subjects With Advanced Solid TumorsPurpose: This is a Phase 1, dose escalation study evaluating safety and pharmacokinetics of enteric coated D-3263 HCl in subjects with advanced solid tumors.
CAS
947257-66-1
Created by admin on Sat Dec 16 18:20:54 GMT 2023 , Edited by admin on Sat Dec 16 18:20:54 GMT 2023
PRIMARY
FDA UNII
70FBL3TX3E
Created by admin on Sat Dec 16 18:20:54 GMT 2023 , Edited by admin on Sat Dec 16 18:20:54 GMT 2023
PRIMARY
NCI_THESAURUS
C162345
Created by admin on Sat Dec 16 18:20:54 GMT 2023 , Edited by admin on Sat Dec 16 18:20:54 GMT 2023
PRIMARY